| |
| |
|
| Insider
Information: |
Ross Thomas M. |
| Relationship: |
|
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
25,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$92,750 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
25,000 |
|
|
| Total
Value |
$92,750 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Maxcyte, Inc. |
MXCT |
|
2024-03-15 |
25,000 |
2022-10-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MXCT |
Maxcyte, Inc. |
EVP, GLOBAL SALES & MARKETING |
• – – |
2024-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-04-12 |
4 |
AS |
$5.00 |
$27,915 |
D/D |
(5,583) |
0 |
0 |
% |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-04-12 |
4 |
OE |
$2.14 |
$11,959 |
D/D |
5,583 |
5,583 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-04-11 |
4 |
AS |
$5.00 |
$42,255 |
D/D |
(8,451) |
0 |
0 |
% |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-04-11 |
4 |
OE |
$2.14 |
$18,102 |
D/D |
8,451 |
8,451 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-04-10 |
4 |
AS |
$5.00 |
$500 |
D/D |
(100) |
0 |
0 |
% |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-04-10 |
4 |
OE |
$2.14 |
$214 |
D/D |
100 |
100 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-04-06 |
4 |
OE |
$2.14 |
$58,247 |
D/D |
27,193 |
27,193 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-04-06 |
4 |
AS |
$5.03 |
$136,781 |
D/D |
(27,193) |
0 |
0 |
% |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-04-05 |
4 |
AS |
$5.00 |
$34,835 |
D/D |
(6,967) |
0 |
0 |
% |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-04-05 |
4 |
OE |
$2.14 |
$14,923 |
D/D |
6,967 |
6,967 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-02-02 |
4 |
AS |
$5.77 |
$66,788 |
D/D |
(11,575) |
0 |
0 |
% |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-02-02 |
4 |
OE |
$2.14 |
$24,794 |
D/D |
11,575 |
11,575 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-02-01 |
4 |
AS |
$5.68 |
$99,729 |
D/D |
(17,558) |
0 |
0 |
% |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-02-01 |
4 |
OE |
$0.98 |
$34,749 |
D/D |
17,558 |
17,558 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-01-05 |
4 |
AS |
$5.04 |
$47,714 |
D/D |
(9,467) |
0 |
0 |
% |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-01-05 |
4 |
OE |
$0.98 |
$9,306 |
D/D |
9,467 |
9,467 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-01-04 |
4 |
AS |
$5.07 |
$46,406 |
D/D |
(9,153) |
0 |
0 |
% |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-01-04 |
4 |
OE |
$0.98 |
$8,997 |
D/D |
9,153 |
9,153 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-01-03 |
4 |
AS |
$5.13 |
$53,932 |
D/D |
(10,513) |
0 |
0 |
% |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2023-01-03 |
4 |
OE |
$0.98 |
$10,334 |
D/D |
10,513 |
10,513 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2022-12-05 |
4 |
AS |
$5.59 |
$79,003 |
D/D |
(14,133) |
0 |
0 |
% |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2022-12-05 |
4 |
OE |
$1.08 |
$15,264 |
D/D |
14,133 |
14,133 |
0 |
- |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2022-12-02 |
4 |
AS |
$6.02 |
$90,300 |
D/D |
(15,000) |
0 |
0 |
% |
|
| MXCT |
Maxcyte, Inc. |
EVP, Global Sales & Marketing |
• – – |
2022-12-02 |
4 |
OE |
$1.08 |
$16,200 |
D/D |
15,000 |
15,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
